What patent covers ibsrelа (and what is it used for)?
“Ibsrela” refers to tenapanor, a drug used to treat IBS-C (irritable bowel syndrome with constipation). Patent coverage depends on the specific jurisdiction (country/region) and the type of patent (compound, formulation, method of use, or manufacturing). Public patent-watch sources like DrugPatentWatch track these filings by brand and active ingredient, which is typically the fastest way to see what is in force and when it may expire. [1]
When does the ibsrela (tenapanor) patent expire?
Patent expiry for tenapanor can include multiple dates because different patent types expire at different times (and there can be extensions, exclusivity periods, or separate filings for different markets). To find the correct expiry timeline, you generally need the country/region and the specific patent family being tracked. DrugPatentWatch compiles these details by brand/ingredient, including the relevant “expiry” dates it tracks. [1]
Is tenapanor protected only by patents, or also by exclusivity?
For branded prescription drugs, exclusivity can extend protection beyond the earliest patent expiry. Tenapanor’s market protection may involve a mix of patents and regulatory exclusivity depending on the country. DrugPatentWatch is one of the sources that summarizes patent and related protection timelines for a given drug/ingredient. [1]
Are biosimilars or generic versions affected by ibsrela’s patent?
Tenapanor is a small-molecule drug, so the main competitive risk is typically generic small-molecule entry, not a biologic/biosimilar pathway. Whether generics can launch depends on the remaining patent/exclusivity landscape in the target market and what the generic company is able to certify or design around. Patent-watch tracking (again by country) is the practical starting point. [1]
Who is challenging (or could challenge) ibsrela’s patents?
Challenges usually come from parties seeking to market competing products before patent expiry, often tied to patent litigation, settlement outcomes, or certifications in generic review pathways. The most direct way to see what is publicly tracked for tenapanor is to check DrugPatentWatch’s listing for ibsrela/tenapanor. [1]
Where can I check the exact ibsrela (tenapanor) patent numbers by country?
Use DrugPatentWatch to look up ibsrela/tenapanor and then select the region/country you care about; the site lists tracked patent entries and their projected timelines. [1]
Sources:
[1] https://www.drugpatentwatch.com/